Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study

por de la Cruz-Merino, Luis, Gion, María, Cruz-Jurado, Josefina, Quiroga, Vanesa, Andrés, Raquel, Moreno, Fernando, Alonso-Romero, Jose L., Ramos, Manuel, Holgado, Esther, Cortés, Javier, López-Miranda, Elena, Henao-Carrasco, Fernando, Palazón-Carrión, Natalia, Rodríguez, Luz M., Ceballos, Isaac, Casas, Maribel, Benito, Sara, Chiesa, Massimo, Bezares, Susana, Caballero, Rosalia, Jiménez-Cortegana, Carlos, Sánchez-Margalet, Víctor, Rojo, Federico
Publicado 2021